September 17, 2019
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- Drugs@FDA Data Files (updated)
- FDA Drug Shortages
- Bupivacaine Hydrochloride and Epinephrine Injection, USP (Updated - Currently in Shortage)
- Buspirone HCl Tablets (New - Currently in Shortage)
- Buspirone HCl Tablets (Updated - Currently in Shortage)
- Cefoxitin for Injection, USP (Updated - Currently in Shortage)
- Dicyclomine Oral Tablets/Capsules (Updated - Currently in Shortage)
- Hydromorphone Hydrochloride Injection, USP (Updated - Currently in Shortage)
- Ketorolac Tromethamine Injection (Updated - Currently in Shortage)
- Leucovorin Calcium Lyophilized Powder for Injection (Updated - Currently in Shortage)
- Morphine Sulfate Injection, USP (Updated - Currently in Shortage)
- Piperacillin and Tazobactam (Zosyn) Injection (Updated - Currently in Shortage)
- Sodium Bicarbonate Injection, USP (Updated - Currently in Shortage)
- Sodium Chloride 23.4% Injection (Updated - Currently in Shortage)
- Sodium Chloride Injection USP, 0.9% Vials and Syringes (Updated - Currently in Shortage)
- Thioridazine Hydrochloride Tablets (Updated - Currently in Shortage)
- Thiothixene Capsules (Updated - Currently in Shortage)
- Vinblastine Sulfate Injection (Updated - Currently in Shortage)
- National Drug Code Directory (updated)
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
- Takeda Issues US Recall of Natpara (parathyroid hormone) for Injection Due to the Potential for Rubber Particulate
.png)
No hay comentarios:
Publicar un comentario